Diet and risk of coronary heart disease and type 2 diabetes

Lancet

Volumn 360, Issue 9335, 2002, Pages 783-789

  Mann, J I ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

SATURATED FATTY ACID;

CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLINICAL TRIAL; CORONARY RISK; DIET; DISEASE ASSOCIATION; FAT INTAKE; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MACRONUTRIENT; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRIENT CONTENT; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOCIAL STATUS;

EID: 0037036968     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)09901-4     Document Type: Review

References (52)

1. Keys A. Seven countries: a multivariate analysis of death and coronary heart disease. 1980;Harvard University Press, Cambridge, MA.
2. Yudkin J., Watson R.H. Sugar and ischaemic heart disease. BMJ. 4:1969;110-111.
3. McMichael J. Fats and atheroma: an inquest. BMJ. 1:1979;173-175.
4. Mann J.I. Fats and atheroma: a retrial. BMJ. 1:1979;732-734.
5. UK Department of Health and Social Security. Diet and cardiovascular disease: report of the panel on diet in relation to cardiovascular disease, Committee on Medical Aspects of Food Policy (Report on Health and Social Subjects; 28). London, UK: HMSO, 1984.
6. UK Department of Health. Nutritional aspects of cardiovascular disease: report of the Cardiovascular Review Group Committee on medical aspects of good policy (Report on Health and Social Subjects; 46). London, UK: HMSO, 1994.
7. Connor W.E., Connor S.L., Katan M.B., Grundy S.M., Willett W.C. Should a low-fat, high-carbohydrate diet be recommended for everyone? N Engl J Med. 337:1997;562-567.
8. Mann J.I. Diet and diabetes. Diabetologia. 18:1980;89-95.
9. The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), 19199 . Recommendations for the nutritional management of patients with diabetes mellitus. Eur J Clin Nutr. 54:2000;353-355.
10. American Diabetes Association . Clinical practice recommendations 2002. Diabetes Care. 25:(suppl):2002;S1-147.
11. Bobak M., Marmot M. The East-West health divide and potential explanations. Harrington P., Ritsatakis A., Health challenges for countries of central and eastern Europe and the newly independent states. 1995;8-43 World Health Organization, Copenhagen.
12. King H., Aubert R.E., Herman W.H. Global burden of diabetes, 1995-2025. Diabetes Care. 21:1998;1414-1431.
13. Mann J. Cardiovascular diseases. Mann J., Truswell A.S., Essentials of Human Nutrition. 2nd edn:2002;299-334 Oxford University Press, Oxford, UK.
14. Storlein L.H., Baur L.A., Kriketos A.D., et al. Dietary fats and insulin action. Diabetologia. 39:1996;621-631.
15. Vessby B., Uusitupa M., Hermansen K., et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU Study. Diabetologia. 44:2001;312-319.
16. Salméron J., Manson J.E., Stampfer M.J., et al. Relative risk of type 2 diabetes mellitus by different levels of cereal fibre intake and glycaemic load. JAMA. 277:1997;472-477.
17. Mann J. Dietary fibre and diabetes revisited. Eur J Clin Nutr. 55:2001;919-921.
18. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva: World Health Organization, 1998.
19. Manson J.E., Rimm E.B., Stampfer M.J., et al. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet. 338:1991;774-778.
20. Hu F.B., Stampfer M.J., Manson J.E., et al. Trends in the ncidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med. 343:2000;530-537.
21. Gray R.P., Yudkin J.S. Cardiovascular disease in diabetes mellitus. Pickup J.C., Williams G., Textbook of diabetes. 2nd edn:1997;57.1-57.22 Blackwell Science, Oxford, UK.
22. Truswell A.S. Levels and kinds of evidence for public-health nutrition. Lancet. 357:2001;1061-1062.
23. Hooper L., Summerbell C.D., Higgins J.P.T., et al. Dietary fat intake and prevention of cardiovascular disease: a systematic review. BMJ. 322:2001;757-763.
24. Hjermann I., Holme I., Byre K.V., Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Lancet. 1:1981;1305-1310.
25. de Lorgeril M., Renaud S., Mamelle N., et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 343:1994;1454-1459.
26. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). Lancet 1994; 344: 1383-89.
27. Kushi L.H., Folsom A.R., Prineas R.J., Mink P.J., Wu Y., Bostock R.M. Dietary antioxidant vitamins and death from coronary heart disease in post menopausal women. N Engl J Med. 334:1996;1156-1162.
28. Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., Willett W.C. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 328:1993;1444-1449.
29. Stephens N.G., Parsons A., Schofield P.M., et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 347:1996;781-786.
30. The Heart Outcomes Prevention Evaluation Study Investigators . Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med. 342:2000;154-160.
31. Devaraj S., Jialal I. Low density lipoprotein postsecretary modification, monocyte function and circulating adhesion molecules in type 2 diabetes patients with and without macrovascular complications: the effects of alpha tocopherol supplementation. Circulation. 102:2000;191-196.
32. Ridker P.M. Role of inflammatory biomarkers in prediction of coronary heart disease. Lancet. 358:2001;946-948.
33. Burr M.L., Gilbert J.F., Holliday R.M., et al. Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial. Lancet. 2:1989;757-761.
34. Gissi Prevenzione Investigators . Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 354:1999;455-477.
35. Homocysteine Lowering Trialists' Collaboration . Lowering blood homocysteine with folic acid based supplements meta-analysis of randomised trials. BMJ. 316:1998;894-898.
36. Riddell L.J., Chisholm A., Williams S., Mann J.I. Dietary strategies for lowering homocysteine concentrations. Am J Clin Nutr. 71:2000;1448-1454.
37. Venn BJ, Mann JI, Williams SM et al. Dietary counselling to raise natural folate intake: randomised placebo controlled trial in free-living individuals to assess the effects on serum folate and plasma total homocysteine. Am J Clin Nutr 2002 (in press).
38. Malinow M.R., Duell P.B., Hess D.L., et al. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med. 338:1998;1009-1015.
39. Schnyder G., Roffi M., Pin R., et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med. 345:2001;1593-1600.
40. Jacques P.F., Selhub J., Bostom A.G., Wilson P.W., Rosenberg I.H. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med. 340:1999;1449-1454.
41. Wallace A.J., Mann J.I., Sutherland W.H.F., et al. Variants in the cholesterol ester transfer protein and lipoprotine lipase genes are predictors of plasma cholesterol response to dietary change. Atherosclerosis. 152:2000;327-336.
42. Lewis B., Mann J.I., Mancini M. Reducing the risks of coronary heart disease in individuals and in the population. Lancet. 1:1986;956-959.
43. Tuomilehto J., Lindstrom J., Eriksson J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjecs with impaired glucose tolerance. N Engl J Med. 344:2001;1343-1350.
44. Diabetes Prevention Program Research Group, Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 346:2002;393-403.
45. Pan X.R., Cao H.B., Li G.W., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 20:1997;537-544.
46. Narayan K.M.V., Bowman B.A., Engelgau M.E. Prevention of type 2 diabetes. BMJ. 323:2001;63-64.
47. McAuley K.A., Williams S.M., Mann J.I., et al. Intensive lifestyle changes are necessary to improve insulin sensitivity: a randomised controlled trial. Diabetes Care. 25:2002;445-452.
48. McAuley K.A., Williams S.M., Mann J.I., et al. Diagnosing insulin resistance in the general population. Diabetes Care. 24:2001;460-464.
49. Clarke P., Gray A., Adler A., et al. UKPDS Group. United Kingdom Prospective Diabetes Study. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No 51). Diabetologia. 44:2001;298-304.
50. Mann J. Stemming the tide of diabetes mellitus. Lancet. 356:2000;1454-1455.
51. Rowley K.G., Gault A., McDermott R., Knight S., McLeay T., O'Dea K. Reduced prevalence of impaired glucose tolerance and no change in prevalence of diabetes despite increasing BMI among Aboriginal people from a group of remote homeland communities. Diabetes Care. 23:2000;898-904.
52. Macaulay A.C., Paradis G., Potvin L., et al. The Kahnawake Schools Diabetes Prevention Project: intervention, evaluation, and baseline community in Canada. Prev Med. 26:1997;779-790.